POXEL SA: Poxel Announces Availability of Its 2021 Universal Registration Document

POXEL SA (Euronext: POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic

Related Keywords

China ,Boston ,Massachusetts ,United States ,Taiwan ,Japan ,Tokyo ,South Korea ,France ,French ,Arthur Rouill ,Sumitomo Pharma ,Enregistrement Universel ,Jean Jaur ,Immeuble Le Sunway , ,Universal Registration Document ,Des March ,Registration Document ,Financial Report ,Management Report ,Corporate Governance ,Corporate Social Responsibility ,Investors Corporate Governance ,Japan Poxel ,Southeast Asian ,Euronext Paris ,Relations Communication Senior Director ,Vice President ,Investor Relations Communication ,Poxel ,Troxel ,Nnounces ,Availability ,021 ,Niversal ,Registration ,Document ,